LookCloser.aipublic supplement evidence
Exact product checked · barcode not publishedScibalia · checked Sep 1, 2026 · on sale since Mar 4, 2026🇨🇳 USPTO wordmark owner · Nanchang jiuhao Commercial Management Co., Ltd. · China
Quick read · Scibalia

Multi Collagen Peptides Liquid Drop w. Types I II III V X…

Checked against public sources on September 1, 2026 · LookCloser does not sell or recommend supplements.

Does the marketing hold up?

🇨🇳 Brand owner: Nanchang jiuhao Commercial Management Co., Ltd. · other, China. This tells you who is behind the brand and where the trademark record points. It does not by itself identify the manufacturer.

Is the dose real?Can’t check — no panel filed
What a serving costsNo price found for this exact barcode
Is it tested?No testing claim made
Who’s behind it?🇨🇳Nanchang jiuhao Commercial Management Co., Ltd.other · China
Is it the real thing?No barcode publishedso it can’t be matched against certification, recall or other retailer records
Trouble on record?✓No recalls found
Quick read · 1 useful finding

What is worth knowing.

Headlines first. Open evidence only when you want the source trail.

CheckedCan you trust the review pattern?

Reviews rose from 20 to 42 between June 3 and August 13, 2026 — no sudden jump.

A count that moves steadily is ordinary. A sudden burst is what deserves a closer look.

Evidence and sources

Written reviews rose from 20 to 42 between June 3 and August 13, 2026. The largest rise inside any single 30-day window was about 13, so the count moved in steps rather than in one burst.

Keepa exact-listing historydated count history · exact listing
Locked evidence record →Open the full source-linked finding
What remains open 1
  • No FDA recall matched this brand in the current search.

These are evidence gaps, not strikes against the product.

Who owns the brand wordmark?
🇨🇳
Nanchang jiuhao Commercial Management Co., Ltd.Other · exact supplement-class mark for SCIBALIA
AssignmentsNo transfers recorded

Filed address
No. 369, Lushan South Avenue, Honggutan District, Room 1013, Nanchang Causeway Bay Plaza Office Building, Nanchang, Jiangxi, 330000, CHINA

USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗

Research behind the findings

Dose and research context

We could not match an amount on this product to a studied range for the same ingredient, so these links are ingredient background rather than a measurement of this product.

PubMed search: collagen peptide supplementation trial ↗WebMD search: collagen ↗NIH ODS — Fiber overview (MVMS context) ↗PubMed search: inulin prebiotic randomized trial ↗
Buying options

Where you can check or buy it

Only the submitted seller page is identity-certain. Other destinations are shown as leads until a shared UPC/GTIN confirms the exact product.

iHerb

Not confirmed
No price confirmed

No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.

Search iHerb ↗

Target

Not confirmed
No price confirmed

No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.

Search Target ↗

Walmart

Not confirmed
No price confirmed

No matching product page was confirmed in the current record. Search results cannot be attached as this product until the UPC/GTIN matches.

Search Walmart ↗

Prices and stock are point-in-time observations. Related pages are never used as product evidence. No affiliate links; LookCloser earns nothing from these sellers.

Want to inspect the evidence?

The full report shows every source, the exact unresolved question, and the documentation that would settle it.

Read / share full evidence →

Record built September 03, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.